In cancer patients, the abundance of T cells with a TRM phenotype correlates with longer disease-free and overall survival in multiple cancer types (reviewed in ref. 26), and is in some studies a better prognostic factor than  the total number of CD8+ T cells27,28. The gene discussed is CD8A; the disease is cancer.